Wuhan Yzy Biopharma Sells Land Use Right and Building to Wuhan Yiruide
I'm PortAI, I can summarize articles.
Wuhan Yzy Biopharma Co. Ltd. has announced a transaction involving the sale of land use rights and buildings to Wuhan Yiruide Medical Treatment Equipment New Technology Co., Ltd. The agreement, signed on January 23, 2026, covers approximately 11,333.22 square meters of gross floor area and is classified as a discloseable transaction under Hong Kong Stock Exchange Listing Rules.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments